Diazyme Sodium Enzymatic Assay
System, Test, Sodium, Enzymatic Method. 510(k) K042189, from Diazyme Laboratories (San Diego, CA). Product code MZU, class 2.
As of Nov 19, 2026, K042189 is an FDA 510(k) held by Diazyme Laboratories, substantially equivalent on Oct 7, 2004 after 56 days, with no recalls tied to it in FDA's recall database.
- Review time: 56 days
- Recalls: 0
Diazyme Sodium Enzymatic Assay Kit in conjunction with Diazyme Sodium Low and High Calibrators, are intended for the quantitative determination of sodium (NA) in serum. Diazyme Sodium Enzymatic Assay Kit contains a low level standard and a high level standard. The standards are used to generate a linear graph that will be used in the calculation of sodium concentrations in unknown serum samples.
- Synchron LX I 725 Clinical SystemK023049 · Beckman Coulter, Inc. · Oct 4, 2002
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Aug 12, 2004
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1665
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files